Lack of T-cell-mediated IL-2 and TNFα production is linked to decreased CD58 expression in intestinal tissue during acute simian immunodeficiency virus infection.

Diganta Pan, Arpita Das, Sudesh K Srivastav, Vicki Traina-Dorge, Peter J Didier, Bapi Pahar
Author Information
  1. Diganta Pan: 1​Division of Comparative Pathology, Covington, Louisiana.
  2. Arpita Das: 2​Division of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
  3. Sudesh K Srivastav: 3​Department of Biostatistics and Bioinformatics, Tulane University, New Orleans, Louisiana, USA.
  4. Vicki Traina-Dorge: 2​Division of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
  5. Peter J Didier: 1​Division of Comparative Pathology, Covington, Louisiana.
  6. Bapi Pahar: 1​Division of Comparative Pathology, Covington, Louisiana.

Abstract

For an effective T-cell activation and response, co-stimulation is required in addition to the antigen-specific signal from their antigen receptors. The CD2/CD58 interaction is considered as one of the most important T-cell co-stimulatory pathways for T-cell activation and proliferation, and its role in regulating intestinal T-cell function in acute and chronic SIV -infected macaques is poorly documented. Here, we demonstrated a significant reduction of CD58 expression in both T- and B-cell populations during acute SIV infection along with high plasma viral load and a loss of intestinal CD4 T cells compared to SIV-uninfected control macaques. The reduction of CD58 expression in T cells was correlated with the reduced expression of T-cell-mediated IL-2 and TNFα production. Together, these results indicate that reduction in the CD2/CD58 interaction pathway in mucosal lymphocytes might play a crucial role in mucosal T-cell dysfunction during acute SIV/HIV infection.

Keywords

References

  1. J Virol. 2014 Aug;88(16):9442-57 [PMID: 24920807]
  2. Clin Immunol. 2011 Sep;140(3):223-8 [PMID: 21622026]
  3. Immunology. 2000 Oct;101(2):169-77 [PMID: 11012769]
  4. Cell Immunol. 2004 May;229(1):1-12 [PMID: 15331323]
  5. Nature. 1987 Mar 26-Apr 1;326(6111):400-3 [PMID: 2951597]
  6. Blood. 2008 Dec 15;112(13):4981-90 [PMID: 18820133]
  7. J Virol. 2013 Mar;87(5):2628-38 [PMID: 23255798]
  8. J Virol. 2013 Apr;87(8):4584-95 [PMID: 23408608]
  9. PLoS One. 2014 Feb 13;9(2):e87873 [PMID: 24551068]
  10. Blood. 2007 Aug 15;110(4):1207-14 [PMID: 17513617]
  11. Gastroenterology. 1999 Mar;116(3):557-65 [PMID: 10029614]
  12. AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S125-30 [PMID: 9581896]
  13. J Virol. 2013 Feb;87(3):1528-43 [PMID: 23152518]
  14. J Immunol. 2011 Jan 15;186(2):745-53 [PMID: 21148794]
  15. Nat Med. 1996 Oct;2(10):1084-9 [PMID: 8837605]
  16. AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1691-701 [PMID: 10606092]
  17. PLoS Pathog. 2016 Feb 01;12(2):e1005412 [PMID: 26829644]
  18. J Clin Invest. 1996 Dec 1;98(11):2616-22 [PMID: 8958226]
  19. J Virol. 2000 Mar;74(5):2255-64 [PMID: 10666256]
  20. Eur J Immunol. 2006 Mar;36(3):583-92 [PMID: 16506292]
  21. J Virol. 2013 Nov;87(21):11916-23 [PMID: 23966391]
  22. Front Biosci. 2006 Jan 01;11:788-803 [PMID: 16146771]
  23. Clin Immunol. 2015 May;158(1):8-18 [PMID: 25769244]
  24. J Acquir Immune Defic Syndr. 2013 Dec 1;64(4):332-41 [PMID: 23799411]
  25. Cell Immunol. 1997 Feb 25;176(1):82-91 [PMID: 9070321]
  26. J Virol. 2014 Nov;88(22):13015-28 [PMID: 25165117]
  27. J Immunol. 2009 Jun 15;182(12):7672-80 [PMID: 19494291]
  28. Immunol Today. 1996 Apr;17(4):177-87 [PMID: 8871350]
  29. J Exp Med. 1998 Dec 21;188(12):2199-204 [PMID: 9858506]
  30. Int Immunol. 1994 May;6(5):701-9 [PMID: 7521667]
  31. PLoS One. 2011;6(11):e27207 [PMID: 22096538]
  32. Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G671-7 [PMID: 19109405]
  33. Virology. 2009 May 10;387(2):273-84 [PMID: 19298994]
  34. ISRN AIDS. 2013 Aug 12;2013:954806 [PMID: 24052891]
  35. Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4180-3 [PMID: 23341590]
  36. Eur J Immunol. 2016 Oct;46(10):2420-2425 [PMID: 27469079]
  37. Virol J. 2016 Dec 1;13(1):200 [PMID: 27903274]
  38. J Immunol. 2015 Jul 15;195(2):477-87 [PMID: 26041540]
  39. Int Immunol. 2001 Feb;13(2):181-91 [PMID: 11157851]
  40. Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1019-23 [PMID: 9927686]
  41. Virology. 2007 Jun 20;363(1):36-47 [PMID: 17307212]

Grants

  1. P20 GM103458/NIGMS NIH HHS
  2. P51 OD011104/NIH HHS
  3. R01 DK109883/NIDDK NIH HHS

MeSH Term

Animals
B-Lymphocytes
CD58 Antigens
Gene Expression
Interleukin-2
Intestinal Mucosa
Intraepithelial Lymphocytes
Lymphocyte Activation
Macaca
Plasma
Simian Acquired Immunodeficiency Syndrome
Simian Immunodeficiency Virus
Tumor Necrosis Factor-alpha
Viral Load

Chemicals

CD58 Antigens
Interleukin-2
Tumor Necrosis Factor-alpha

Word Cloud

Created with Highcharts 10.0.0T-cellacuteCD58expressionintestinalSIVreductioninfectionmucosalactivationCD2/CD58interactionrolemacaquesTcellsT-cell-mediatedIL-2TNFαproductioneffectiveresponseco-stimulationrequiredadditionantigen-specificsignalantigenreceptorsconsideredoneimportantco-stimulatorypathwaysproliferationregulatingfunctionchronic-infectedpoorlydocumenteddemonstratedsignificantT-B-cellpopulationsalonghighplasmaviralloadlossCD4comparedSIV-uninfectedcontrolcorrelatedreducedTogetherresultsindicatepathwaylymphocytesmightplaycrucialdysfunctionSIV/HIVLacklinkeddecreasedtissuesimianimmunodeficiencyvirusCD2cytokineimmunology

Similar Articles

Cited By